Oruka Therapeutics, Inc. (ORKA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$8.32M2011: -$6.96M2012: -$4.08M2017: -$17.47M2018: -$8.24M2019: -$4.80M2020: -$7.72M2021: -$18.76M2022: -$10.91M2023: -$5.01M2025: -$88.21M-$88.21M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$88.21M
2023-$5.01M+54.1%
2022-$10.91M+41.8%
2021-$18.76M-142.9%
2020-$7.72M-60.9%
2019-$4.80M+41.8%
2018-$8.24M+52.8%
2017-$17.47M
2012-$4.08M+41.4%
2011-$6.96M+16.4%
2010-$8.32M